Hits: 13
The Food and Drug Administration has been in “sustained and ongoing” discussions with Gilead Sciences to make antiviral drug remdesivir available to Covid-19 patients “as quickly as possible, as appropriate,” the agency said. Source
Hits: 13
The Food and Drug Administration has been in “sustained and ongoing” discussions with Gilead Sciences to make antiviral drug remdesivir available to Covid-19 patients “as quickly as possible, as appropriate,” the agency said. Source
Copyright © 2019 | 0pd.net
Be the first to comment